impact of maternal pre-pregnancy dyslipidemia exposure on adult offspring lipid levels

1
Characterization of aortic remodeling following Kawasaki disease: Toward a fully-developed automatic bi-parametric model. Medical Physics 2012;30(10):6104-6110. Neonatal and current biometric data IUGR (n=18) Normal (n=17) p value Birth-weight (g) 1 438 ± 614 3 317 ± 510 0.000 Umbilical artery pulsatility index 1.54 ± 0.36 1.23 ± 0.21 0.007 Current Weight (z-score -0.18 ± 1.05 0.48 ± 1.14 0.089 Current Height (z-score) -0.52 ± 0.88 0.43 ± 1.23 0.013 Current BMI (z-score) -0.06 ± 1.08 0.22 ± 1.25 0.746 Current Systolic BP (z-score) 0.38 ± 0.72 -0.27 ± 0.91 0.023 Current Diastolic BP (z-score) 0.08 ± 0.65 -0.26 ± 0.57 0.103 HSFQ, CMIRA Accueil Pro, Labex PRIMES, Labex CELYA Featured Research 140 IMPACT OF MATERNAL PRE-PREGNANCY DYSLIPIDEMIA EXPOSURE ON ADULT OFFSPRING LIPID LEVELS M Mendelson, A Lyass, RB D'Agostino, Sr., D Levy Boston, Massachusetts OBJECTIVE: To examine the relationship between maternal hypercholesterolemia prior to pregnancy and variations in adult offspring lipid levels. BACKGROUND: Maternal health and in utero exposures are important determinants of cardiovascular disease outcomes among adult offspring. The risk of developing dyslipidemia is not fully explained by known genetic variants and lifestyle factors. Epigenetic factors, inuenced by maternal inheritance or fetal intrauterine exposure, may explain part of the vari- ability and missing heritabilityof lipid traits. METHODS: Analysis of prospectively collected clinical and labo- ratory data from the three generations of Framingham Heart Study (FHS) participants. The study sample included adult offspring in the second and third generation cohorts of the FHS with maternal examinations prior to the participantsbirth. The primary outcome was offspring total cholesterol (TC) and secondary outcomes included LDL and HDL, measured at the rst assessment in the FHS, with all outcomes examined as continuous and dichotomous variables. Dyslipidemia was dened as TC 5.17mmol/L, LDL 3.36mmol/L, or HDL <1.03mmol/L in men and <1.29mmol/L in women. Exposure measures included maternal lipids (TC, LDL, and HDL) prior to pregnancy with the effect of maternal lipids w30 years after pregnancy used as a comparison group. Analysis included summary statistics, and multiple linear and logistic regression models adjusting for age, gender, and additional covariates. RESULTS: There were 493 FHS participants with maternal ex- aminations prior to pregnancy. The average maternal age at assessment was 31 (SD 6) years, BMI 22.9 (3.2) kg/m2, and the average offspring age at assessment was 22 (5) years, BMI 24.2 (4.8) kg/m2. In fully adjusted models, the odds ratio for offspring dyslipidemia was increased to 3.2 (95% CI 1.6-3.2, p¼0.0008) from 1.9 (1.0-3.5, p¼0.044) for abnormal TC, increased to 4.7 (2.0-11, p¼0.0004) from 1.6 (0.8-3.5, p¼0.21) for abnormal LDL, and decreased to 2.5 (1.3-5.0, p¼0.008) from 6.7 (2.5-18, p¼0.0002) for abnormal HDL, with exposure to maternal pre- pregnancy as compared to post-pregnancy dyslipidemia. CONCLUSION: The odds of adult offspring dyslipidemia with abnormal TC and LDL are w1.5 and 3x greater, respectively, if the mother had dyslipidemia prior to pregnancy as compared to dyslipidemia post-pregnancy. Further research examining the inuence of maternal dyslipidemia exposure on offspring epigenetic elements, especially modiable factors, in relation to lipid and CVD outcomes, is needed. Interventions to reduce dyslipidemia among women prior to pregnancy may inuence maladaptive epigenetic changes and modify the vicious trans- generational cycle of dyslipidemia and CVD-morbidity. 141 MATERNAL HYPOTHYROIDISM MAY BE ASSOCIATED WITH CONGENITAL HEART DISEASE IN OFFSPRING M Grattan, D Thomas, L Hornberger, R Hamilton, W Midodzi, S Vohra Edmonton, Alberta OBJECTIVES: This study tested whether mothers with maternal hypothyroidism had increased odds of congenital heart disease (CHD) in their offspring. BACKGROUND: Maternal hypothyroidism increases the risk of fetal demise, prematurity and pre-eclampsia, and can negatively impact on neurodevelopment. Prior studies have postulated a relationship between maternal thyroid function and CHD but this relationship has not been directly investigated. METHODS AND RESULTS: A retrospective maternal-child dyads survey was conducted in the Echocardiography Laboratory at the Hospital for Sick Children, Toronto, Canada over a 17 month period to obtain a history of maternal thyroid status. Pediatric echocardiograms were evaluated prospectively for CHD by a blinded pediatric cardiologist. Logistic analysis was performed to examine the association between CHD and maternal hypothyroidism. Of the 998 maternal-child dyads with complete data, 10% (99/998) of the mothers reported a history of prenatal hy- pothyroidism. The overall incidence of CHD in the study sample was 63.1% (630/998). Mothers with a history of hypothyroidism were signicantly more likely to have offspring with CHD (72.4%) compared to mothers without a history of hypothyroidism (61.1%). After adjustment in the multivariate model for maternal age (>35 years), risk of fetal aneuploidy, maternal diabetes and family history of CHD, the odds ratio (95% condence interval) for CHD in offspring associated with reported maternal hypothyroidism was 1.68 (1.02-2.78). CONCLUSION: This study suggests that maternal hypothy- roidism is a risk factor for the development of CHD. Further S144 Canadian Journal of Cardiology Volume 29 2013

Upload: d

Post on 30-Dec-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

S144 Canadian Journal of CardiologyVolume 29 2013

Characterization of aortic remodeling following Kawasakidisease: Toward a fully-developed automatic bi-parametricmodel. Medical Physics 2012;30(10):6104-6110.

Neonatal and current biometric dataIUGR (n=18) Normal (n=17) p value

Birth-weight (g) 1 438 ± 614 3 317 ± 510 0.000

Umbilical artery pulsatility index 1.54 ± 0.36 1.23 ± 0.21 0.007

Current Weight (z-score -0.18 ± 1.05 0.48 ± 1.14 0.089

Current Height (z-score) -0.52 ± 0.88 0.43 ± 1.23 0.013

Current BMI (z-score) -0.06 ± 1.08 0.22 ± 1.25 0.746

Current Systolic BP (z-score) 0.38 ± 0.72 -0.27 ± 0.91 0.023

Current Diastolic BP (z-score) 0.08 ± 0.65 -0.26 ± 0.57 0.103

HSFQ, CMIRA Accueil Pro, Labex PRIMES, Labex CELYA

Featured Research

140IMPACT OF MATERNAL PRE-PREGNANCY DYSLIPIDEMIAEXPOSURE ON ADULT OFFSPRING LIPID LEVELS

M Mendelson, A Lyass, RB D'Agostino, Sr., D Levy

Boston, Massachusetts

OBJECTIVE: To examine the relationship between maternalhypercholesterolemia prior to pregnancy and variations inadult offspring lipid levels.BACKGROUND: Maternal health and in utero exposures areimportant determinants of cardiovascular disease outcomesamong adult offspring. The risk of developing dyslipidemia isnot fully explained by known genetic variants and lifestylefactors. Epigenetic factors, influenced by maternal inheritanceor fetal intrauterine exposure, may explain part of the vari-ability and ‘missing heritability’ of lipid traits.METHODS: Analysis of prospectively collected clinical and labo-ratory data from the three generations of Framingham HeartStudy (FHS) participants. The study sample included adultoffspring in the second and third generation cohorts of the FHSwith maternal examinations prior to the participants’ birth. Theprimary outcome was offspring total cholesterol (TC) andsecondary outcomes included LDL and HDL, measured at thefirst assessment in the FHS, with all outcomes examined ascontinuous and dichotomous variables. Dyslipidemia wasdefined as TC �5.17mmol/L, LDL �3.36mmol/L, or HDL<1.03mmol/L in men and<1.29mmol/L in women. Exposuremeasures includedmaternal lipids (TC, LDL, andHDL) prior topregnancy with the effect of maternal lipids w30 years afterpregnancy used as a comparison group. Analysis includedsummary statistics, and multiple linear and logistic regressionmodels adjusting for age, gender, and additional covariates.RESULTS: There were 493 FHS participants with maternal ex-aminations prior to pregnancy. The average maternal age at

assessment was 31 (SD 6) years, BMI 22.9 (3.2) kg/m2, and theaverage offspring age at assessment was 22 (5) years, BMI 24.2(4.8) kg/m2. In fully adjusted models, the odds ratio for offspringdyslipidemia was increased to 3.2 (95% CI 1.6-3.2, p¼0.0008)from 1.9 (1.0-3.5, p¼0.044) for abnormal TC, increased to 4.7(2.0-11, p¼0.0004) from 1.6 (0.8-3.5, p¼0.21) for abnormalLDL, and decreased to 2.5 (1.3-5.0, p¼0.008) from 6.7 (2.5-18,p¼0.0002) for abnormal HDL, with exposure to maternal pre-pregnancy as compared to post-pregnancy dyslipidemia.CONCLUSION: The odds of adult offspring dyslipidemia withabnormal TC and LDL arew1.5 and 3x greater, respectively, ifthe mother had dyslipidemia prior to pregnancy as compared todyslipidemia post-pregnancy. Further research examining theinfluence of maternal dyslipidemia exposure on offspringepigenetic elements, especially modifiable factors, in relation tolipid and CVD outcomes, is needed. Interventions to reducedyslipidemia among women prior to pregnancy may influencemaladaptive epigenetic changes and modify the vicious trans-generational cycle of dyslipidemia and CVD-morbidity.

141MATERNAL HYPOTHYROIDISM MAY BE ASSOCIATED WITHCONGENITAL HEART DISEASE IN OFFSPRING

M Grattan, D Thomas, L Hornberger, R Hamilton, W Midodzi,S Vohra

Edmonton, Alberta

OBJECTIVES: This study tested whether mothers with maternalhypothyroidism had increased odds of congenital heart disease(CHD) in their offspring.BACKGROUND: Maternal hypothyroidism increases the risk offetal demise, prematurity and pre-eclampsia, and can negativelyimpact on neurodevelopment. Prior studies have postulateda relationship between maternal thyroid function and CHDbut this relationship has not been directly investigated.METHODS AND RESULTS: A retrospective maternal-child dyadssurvey was conducted in the Echocardiography Laboratory atthe Hospital for Sick Children, Toronto, Canada over a 17month period to obtain a history of maternal thyroid status.Pediatric echocardiograms were evaluated prospectively forCHD by a blinded pediatric cardiologist. Logistic analysis wasperformed to examine the association between CHD andmaternal hypothyroidism.

Of the 998 maternal-child dyads with complete data, 10%(99/998) of the mothers reported a history of prenatal hy-pothyroidism. The overall incidence of CHD in the studysample was 63.1% (630/998). Mothers with a history ofhypothyroidism were significantly more likely to have offspringwith CHD (72.4%) compared to mothers without a history ofhypothyroidism (61.1%). After adjustment in the multivariatemodel for maternal age (>35 years), risk of fetal aneuploidy,maternal diabetes and family history of CHD, the odds ratio(95% confidence interval) for CHD in offspring associated withreported maternal hypothyroidism was 1.68 (1.02-2.78).CONCLUSION: This study suggests that maternal hypothy-roidism is a risk factor for the development of CHD. Further